Michel Chérel

3.9k citations

117 papers · 2.8k indexed · h-index 32

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Oncology top 5%
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions

Papers in

Radiology, Nuclear Medicine and Imaging 83
- Radiopharmaceutical Chemistry and Applications 71
- Monoclonal and Polyclonal Antibodies Research 26
- Medical Imaging Techniques and Applications 21
Oncology 33
- Peptidase Inhibition and Analysis 17

Co-authors: Alain Faivre-Chauvet François Davodeau Françoise Kraeber‐Bodéré Jacques Barbet François Guérard Jean‐François Gestin Sébastien Gouard Mickaël Bourgeois
Journals: Frontiers in Medicine (10 papers)Cancers (6 papers)International Journal of Molecular Sciences (4 papers)EJNMMI Research (4 papers)Radiation Research (3 papers)
Partner nations: France United States Germany

In The Last Decade

Michel Chérel

115 papers receiving 2.8k citations

Peers

Countries citing papers authored by Michel Chérel

Since Specialization

Citations

This map shows the geographic impact of Michel Chérel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Chérel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Chérel more than expected).

Fields of papers citing papers by Michel Chérel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Chérel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Chérel. The network helps show where Michel Chérel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michel Chérel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel Chérel Line = papers co-authored together Michel Chérel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	« Optimizing Imaging and Dose–Reponse in Radiotherapies » XVIe édition de l’atelier organisé par le réseau « Vectorisation, Imagerie, Radiothérapies » du Cancéropôle Grand-Ouest – 4–7 octobre 2023, Erquy, France Bulletin du Cancer ·پگاه جمشیدی, Vincent Potiron, Nicolas Lepareur, Latifa Rbah‐Vidal, Emmanuel Garcion, T. Ehlersson, Michel Chérel, Raphaël Tripier, Jacques Barbet	2025	0
2	Current landscape and future directions of targeted-alpha-therapy for glioblastoma treatment Theranostics ·EDUARDO MAURO BAPTISTA BOLONHEZ, François Hindré, P Talathi, Franck Lacœuille, Audrey Rousseau, Jean‐Michel Lemée, Emmanuel Garcion, Michel Chérel	2025	5
3	Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [211At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care Cancers ·Caroline Rousseau, 苏腾, Marie‐Françoise Heymann, Maher Kamoun, ALINE DA SILVA COUTINHO, 克広谷口, S. V. Frolova, Nageh K. Allam, Joëlle Gaschet, Romain Eychenne, François Guérard, Jean‐François Gestin, J. Lazzarin, Michel Chérel	2025	3
4	Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice EBioMedicine ·EDUARDO MAURO BAPTISTA BOLONHEZ, Séverine Marionneau‐Lambot, Jan Miller, Romain Eychenne, Sébastien Gouard, Sylvie Avril, Nicolas Chouin, Jérémie Riou, E-L. Kupila, Dhkra Khalil Ibrahim Al-Amiri, Chiara Cattaneo, François Hindré, Michel Chérel, Emmanuel Garcion	2024	11
5	Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma Pharmaceutics ·Xavier Ramírez Roma, L. Vanelderen, Joëlle Gaschet, Arshita Srivastava, Séverine Marionneau‐Lambot, Peter O. Hofgaard, Bjarne Bogen, 一夫青木, Nathalie Le Bris, Raphaël Tripier, Cyrille Alliot, Férid Haddad, Michel Chérel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah‐Vidal	2023	6
6	Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight” Pharmaceutics ·Romain Eychenne, Michel Chérel, Férid Haddad, François Guérard, Jean‐François Gestin	2021	132
7	Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for ⁶⁴ Cu-PET Imaging: Synthesis, Physicochemical Studies, Radiolabeling, and Bioimaging Inorganic Chemistry ·Richard C. Knighton, Thibault Troadec, Valérie Mazan, L. Vanelderen, Séverine Marionneau‐Lambot, Nodirbek Juraboev, Henriette K. Henriksen, Nathalie Le Bris, Michel Chérel, Alain Faivre-Chauvet, Mourad Elhabiri, Loı̈c J. Charbonnière, Raphaël Tripier	2021	16
8	²¹¹At and ¹²⁵I‐Labeling of (Hetero)Aryliodonium Ylides: Astatine Wins Again Chemistry - A European Journal ·messaouda hmaidi, M. Elyan, Romain Eychenne, Joëlle Gaschet, Michel Chérel, Jean‐François Gestin, François Guérard	2021	15
9	Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies Chemical Science ·M. Elyan, Sébastien Gouard, Romain Eychenne, Séverine Marionneau‐Lambot, Mikaël Croyal, Alain Faivre-Chauvet, Michel Chérel, Joëlle Gaschet, Jean‐François Gestin, François Guérard	2020	31
10	What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model International Journal of Molecular Sciences ·Clément Bailly, Sébastien Gouard, François Guérard, 정도회, Thomas Carlier, Alain Faivre-Chauvet, Lihui Xu, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah‐Vidal, Raphaël Tripier, Férid Haddad, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin, Michel Chérel	2019	23
11	TE1PA as Innovating Chelator for ⁶⁴Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model Bioconjugate Chemistry ·Caroline Phegan, Nodirbek Juraboev, L. Vanelderen, Nathalie Le Bris, Clément Bailly, Catherine Saï-Maurel, Mickaël Bourgeois, Michel Chérel, Raphaël Tripier, Alain Faivre-Chauvet	2019	22
12	Synthesis of C-functionalized TE1PA and comparison with its analogues. An example of bioconjugation on 9E7.4 mAb for multiple myeloma ⁶⁴Cu-PET imaging Organic & Biomolecular Chemistry ·Nodirbek Juraboev, Caroline Phegan, Nathalie Le Bris, L. Vanelderen, Sébastien Gouard, Férid Haddad, Jean‐François Gestin, Michel Chérel, Alain Faivre-Chauvet, Raphaël Tripier	2018	22
13	Efficacy of Astatine-211 radioimmunotherapy of Multiple Myeloma using an anti-mCD138 monoclonal antibody in a syngeneic murine model European Journal of Nuclear Medicine and Molecular Imaging ·Sébastien Gouard, 정도회, Catherine Saï-Maurel, François Guérard, 노태욱, Jean‐François Gestin, Nicolas Chouin, Férid Haddad, Cyrille Alliot, Françoise Kraeber‐Bodéré, François Davodeau, Michel Chérel	2018	1
14	Cyclam te1pa for⁶⁴Cu PET imaging. Bioconjugation to antibody, radiolabeling and preclinical application in xenografted colorectal cancer RSC Advances ·惠教宇野, L. Vanelderen, Maryline Beyler, Caroline Phegan, Catherine Saï-Maurel, Cyrille Alliot, Michel Chérel, Jean‐François Gestin, Alain Faivre-Chauvet, Raphaël Tripier	2017	17
15	211 At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds European Journal of Medicinal Chemistry ·C. O. S. B. Brooke, Julien Pilmé, David Tezé, 健司滝井, Jacques Barbet, Michel Chérel, Julie Champion, Rémi Maurice, Shaomeng Pei, Nicolas Galland	2016	32
16	Implementation of a Microdosimetric Model for Radioimmunotherapeutic Alpha Emitters Cancer Biotherapy and Radiopharmaceuticals ·Nicolas Chouin, NosiphoTheyise, A. Lisbona, Michel Chérel, François Davodeau, Jacques Barbet, Manuel Bardiès	2007	3
17	Cancer radioimmunotherapy with alpha-emitting nuclides European Journal of Nuclear Medicine and Molecular Imaging ·Olivier Couturier, S. Supiot, G.L. Patton, Alain Faivre-Chauvet, Thomas Carlier, Jean‐François Chatal, François Davodeau, Michel Chérel	2005	135
18	Traceurs fluorés de la prolifération des cancers en tomographie par émission de positons Médecine Nucléaire ·Olivier Couturier, Caroline Bodet‐Milin, Michel Chérel, Roland Hustinx	2004	1
19	Reconstitution of two isoforms of the human interleukin‐11 receptor and comparison of their functional properties FEBS Letters ·B. Lebeau, Cassiana Hygino Machado, John Wijdenes, Gerhard Müller‐Newen, Heike Dahmen, Michel Chérel, Peter C. Heinrich, Hervé Brailly, Marie‐Martine Hallet, Anne Godard, Stéphane Minvielle, Yannick Jacques	1997	29
20	The Human Interleukin-11 Receptor α Gene (IL11RA): Genomic Organization and Chromosome Mapping Genomics ·Michel Chérel, M. Sorel, Françoise Apiou, B. Lebeau, Sigrid Dubois, Yannick Jacques, Stéphane Minvielle	1996	7

About Michel Chérel

Michel Chérel is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Hematology, Radiation and Immunology, having authored 117 papers that have together received 2.8k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (71 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), Medical Imaging Techniques and Applications (21 papers), Peptidase Inhibition and Analysis (17 papers), Multiple Myeloma Research and Treatments (12 papers), Medical Imaging and Pathology Studies (9 papers), Radiation Therapy and Dosimetry (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.6k citations), Oncology (870 citations), Hematology (256 citations), Radiation (195 citations) and Immunology (466 citations). Michel Chérel has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Alain Faivre-Chauvet, François Davodeau, Françoise Kraeber‐Bodéré, Jacques Barbet, François Guérard, Jean‐François Gestin, Sébastien Gouard, Mickaël Bourgeois, Joëlle Gaschet and Férid Haddad. Their work appears in journals such as Frontiers in Medicine, Cancers, International Journal of Molecular Sciences, EJNMMI Research and Radiation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact